Scarica l'app Stockscreener
34.87
0.51%
-0.18
Dopo l'orario di chiusura:
34.70
-0.17
-0.49%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TGTX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$35.05
Aprire:
$34.86
Volume 24 ore:
1.90M
Relative Volume:
0.88
Capitalizzazione di mercato:
$5.53B
Reddito:
$264.79M
Utile/perdita netta:
$-14.36M
Rapporto P/E:
-317.00
EPS:
-0.11
Flusso di cassa netto:
$-28.11M
1 W Prestazione:
-0.29%
1M Prestazione:
+9.00%
6M Prestazione:
-8.74%
1 anno Prestazione:
+42.33%
Intervallo 1D:
$34.20
$35.64
Intervallo di 1 settimana:
$33.10
$35.64
Portata 52W:
$22.61
$46.48
Tg Therapeutics Inc Stock (TGTX) Company Profile
Nome
Tg Therapeutics Inc
Settore
Industria
Telefono
(212) 554-4484
Indirizzo
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Confronta TGTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
34.87 | 5.42B | 264.79M | -14.36M | -28.11M | -0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-06 | Ripresa | H.C. Wainwright | Buy |
| 2025-07-10 | Ripresa | Goldman | Neutral |
| 2024-10-29 | Iniziato | TD Cowen | Buy |
| 2023-08-02 | Aggiornamento | Goldman | Sell → Neutral |
| 2023-06-26 | Ripresa | Jefferies | Buy |
| 2022-05-20 | Iniziato | BofA Securities | Underperform |
| 2022-02-23 | Reiterato | B. Riley Securities | Buy |
| 2021-11-15 | Downgrade | Goldman | Neutral → Sell |
| 2021-04-20 | Iniziato | Goldman | Neutral |
| 2021-04-19 | Reiterato | H.C. Wainwright | Buy |
| 2020-09-01 | Iniziato | JP Morgan | Overweight |
| 2020-08-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-05 | Iniziato | Evercore ISI | Outperform |
| 2020-01-17 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-27 | Ripresa | B. Riley FBR | Buy |
| 2019-02-06 | Ripresa | Jefferies | Buy |
| 2018-09-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | Reiterato | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | Ripresa | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | Ripresa | H.C. Wainwright | Buy |
| 2017-04-25 | Iniziato | Jefferies | Buy |
| 2017-03-06 | Reiterato | FBR & Co. | Outperform |
| 2016-10-06 | Ripresa | Brean Capital | Buy |
| 2016-05-27 | Iniziato | SunTrust | Buy |
| 2015-12-01 | Iniziato | FBR Capital | Outperform |
| 2015-09-09 | Iniziato | Raymond James | Strong Buy |
| 2015-08-12 | Ripresa | H.C. Wainwright | Buy |
| 2015-06-19 | Reiterato | Brean Capital | Buy |
| 2014-12-11 | Reiterato | ROTH Capital | Buy |
| 2014-12-10 | Reiterato | ROTH Capital | Buy |
Mostra tutto
Tg Therapeutics Inc Borsa (TGTX) Ultime notizie
Market reaction to TG Therapeutics Inc.’s recent newsM&A Rumor & Risk Managed Investment Entry Signals - newser.com
Is TG Therapeutics Inc. forming a reversal patternAnalyst Downgrade & Reliable Price Action Trade Plans - newser.com
Can TG Therapeutics Inc. stock resist market sell offsQuarterly Trade Summary & High Yield Stock Recommendations - newser.com
Evaluating TG Therapeutics Inc. with trendline analysis2025 Fundamental Recap & Weekly High Return Forecasts - newser.com
TG Therapeutics Inc. stock chart pattern explained2025 Year in Review & Daily Profit Maximizing Tips - newser.com
What candlestick patterns are forming on TG Therapeutics Inc.July 2025 Recap & AI Based Trade Execution Alerts - newser.com
What dividend safety score for TG Therapeutics Inc. stock2025 Fundamental Recap & Weekly High Return Forecasts - newser.com
How TG Therapeutics Inc. stock compares to industry benchmarksMarket Risk Analysis & Low Risk Investment Opportunities - newser.com
Published on: 2025-10-14 02:23:58 - newser.com
Is TG Therapeutics Inc. forming a bottoming baseWeekly Risk Report & Daily Chart Pattern Signals - newser.com
How risky is TG Therapeutics Inc. (NKB2) stock compared to peersMarket Growth Review & Growth-Oriented Investment Plans - newser.com
Published on: 2025-10-13 09:09:08 - newser.com
Published on: 2025-10-13 08:45:12 - newser.com
TG Therapeutics, Inc. (TGTX) Investor Outlook: Exploring a 29% Upside in the Biotech Sector - DirectorsTalk Interviews
Is TG Therapeutics Inc. stock bottoming outJuly 2025 Market Mood & High Yield Equity Trading Tips - newser.com
What makes TG Therapeutics Inc. (NKB2) stock appealing to growth investorsMarket Risk Analysis & High Return Stock Watch Alerts - newser.com
Is TG Therapeutics Inc. still worth holding after the dipJuly 2025 Retail & Verified Chart Pattern Trade Signals - newser.com
Is TG Therapeutics Inc. reversing from oversold territoryMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
What indicators show strength in TG Therapeutics Inc.Dividend Hike & Expert Approved Momentum Trade Ideas - newser.com
Analysts Offer Predictions for TG Therapeutics Q3 Earnings - MarketBeat
What analysts say about TG Therapeutics Inc stockEarnings Forecast Updates & Identify Breakout Stocks - earlytimes.in
TG Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Strong Performance Metrics - Markets Mojo
HC Wainwright Weighs in on TG Therapeutics FY2029 Earnings - MarketBeat
TG Therapeutics raises 2025 guidance to $560M, driven by BRIUMVI adoption - MSN
TGTX Receives 'Buy' Rating from HC Wainwright & Co. with $60 Pri - GuruFocus
TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with Significant Growth Potential - DirectorsTalk Interviews
Analyzing TG Therapeutics Inc. with risk reward ratio chartsQuarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com
Detecting support and resistance levels for TG Therapeutics Inc.July 2025 Drop Watch & Fast Moving Trade Plans - newser.com
Institutional investors are TG Therapeutics, Inc.'s (NASDAQ:TGTX) biggest bettors and were rewarded after last week's US$176m market cap gain - Yahoo Finance
What TG Therapeutics (TGTX)'s Six-Year BRIUMVI Safety Data Means For Shareholders - Yahoo Finance
A Look at TG Therapeutics (TGTX) Valuation Following Positive Six-Year BRIUMVI Trial Results - Sahm
TG Therapeutics, Inc.'s (NASDAQ:TGTX) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 5.8% Over Last Week - 富途牛牛
Key metrics from TG Therapeutics Inc.’s quarterly dataTrade Volume Summary & Precise Buy Zone Identification - newser.com
Can TG Therapeutics Inc. stock rebound after recent weaknessBear Alert & Real-Time Stock Movement Alerts - newser.com
What TG Therapeutics, Inc.'s (NASDAQ:TGTX) 26% Share Price Gain Is Not Telling You - Sahm
Tg Therapeutics Inc Azioni (TGTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):